跳至主要内容
临床试验/IRCT20080901001165N58
IRCT20080901001165N58已完成未知

Investigating the efficacy and safety of Plasmapheresis in patients with Moderate to severe COVID-19

Bagheiat-allah University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Confirmed diagnosis of COVID-19, with either lung CT-Scan result, which is typical for COVID-19 pulmonary involvement,or RT-PCR confirmation.
  • The patient/Legal guardian has written consciously and freely consent to participate in the study;
  • The patient has moderate to severe Corona-Virus associated pneumonia;
  • In the first 48 hours of hospitalization, the patient did not show an improving trend;
  • In the first 48 hours after his/her inclusion into this study, there is no possibility of discharge from the patient's hospital;

排除标准

  • Multi organ failure;

研究者

发起方
Bagheiat-allah University of Medical Sciences

相似试验